For the Inventor, By the Inventor

Enter assignee name

Leiden, Netherlands

Pharming B.v.

USPTO Granted Patents = 14

Forward Citations = 1,046

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Frank R Pieper (7 out of 9 patents)

Rein Strijker (6 out of 7 patents)

Paul J Krimpenfort (6 out of 7 patents)

4. Sang He Lee (5 out of 8 patents)

5. Herbert L Heyneker (5 out of 33 patents)

6. Gerard Platenburg (5 out of 5 patents)

7. Herman A DeBoer (4 out of 4 patents)

8. Jeffrey M Rosen (2 out of 5 patents)

9. Harry H Van Veen (2 out of 3 patents)

10. Harry M Meade (1 out of 22 patents)

11. Richard A Berg (1 out of 56 patents)

12. Juhani Jänne (1 out of 2 patents)

13. Jan Henricus Nuijens (1 out of 3 patents)

14. Robert M Kay (1 out of 34 patents)

15. Herman A Deboer (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 6140552 - Production of recombinant polypeptides by bovine species and transgenic (2000-10-31),

2. 6118045 - Lysosomal proteins produced in the milk of transgenic animals (2000-09-12),

3. 6111165 - Production of human recombinant collagen in the milk of transgenic (2000-08-29),

4. 6066725 - Production of recombinant polypeptides by bovine species and transgenic (2000-05-23),

5. 6013857 - Transgenic bovines and milk from transgenic bovines (2000-01-11),

6. 5994616 - Targeted synthesis of protein in mammary gland of a non-human transgenic (1999-11-30),

7. 5959171 - Method for the production of biologically active polypeptides in a mammal's (1999-09-28),

8. 5919913 - Isolation of lactoferrin from milk (1999-07-06),

9. 5861491 - Isolation of lactoferrin from milk (1999-01-19),

10. 5750172 - Transgenic non human mammal milk (1998-05-12),

11. 5741957 - Transgenic bovine (1998-04-21),

12. 5721367 - Homologous recombination in mammalian cells (1998-02-24),

13. 5633076 - Method of producing a transgenic bovine or transgenic bovine embryo (1997-05-27),

14. 5565362 - DNA sequences to target proteins to the mammary gland for efficient (1996-10-15),

Company Overview

Pharming B.V. is a biotechnology company based in Leiden, Netherlands, specializing in the development of innovative therapies for rare diseases. The company focuses on recombinant protein production and advanced biopharmaceuticals, leveraging its proprietary technology to create treatments that address unmet medical needs. Pharming's research primarily centers on genetic disorders and conditions requiring enzyme replacement therapy, positioning it as a key player in the biopharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

14 Patents

#16 in Leiden

#482 in Netherlands

#42,290 in the World

Leiden, Netherlands

Pharming B.v.

Forward Citations = 1,046

23 inventors:

Frank R Pieper (7 out of 9 patents)

Rein Strijker (6 out of 7 patents)

Paul J Krimpenfort (6 out of 7 patents)

4. Sang He Lee (5 out of 8 patents)

5. Herbert L Heyneker (5 out of 33 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pharming B.v.. Retrieved from https://idiyas.com/company/pharming-b-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…